MedTrace Logo

Intraoperative Margin Assessment During Mohs Surgery

NCT02750033 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-08-20

No results posted yet for this study

Summary

The research team will develop an intraoperative handheld device for assessing surgical margins during Mohs surgery. The device technology is based on multimodal optical spectroscopy (MMS), combining three optical spectroscopy techniques into one device. The researchers will first acquire proof of concept MMS measurements within the Mohs surgery suite immediately after surgical excision and prior to histological processing. MMS measurements will be acquired directly on the patient from the NMSC excision site. The final outcome of this study will result in the sensitivity and specificity of MMS compared to histopathology during Mohs surgery. These results will allow for the estimation of the potential benefit of an intraoperative margin assessment technique.

Conditions

  • Squamous Cell Carcinoma (SCC)
  • Basal Cell Carcinoma (BCC)

Interventions

DEVICE

Multimodal Spectroscopy (MMS)

surgical margin assessment with multimodal optical spectroscopy (MMS) device

Sponsors & Collaborators

  • University of Texas at Austin

    collaborator OTHER

  • Dell Medical School at The University of Texas at Austin

    collaborator UNKNOWN

  • Seton Healthcare Family

    lead OTHER

Principal Investigators

  • Jason Reichenberg, MD · Seton Healthcare Family

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2016-12-31
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02750033 on ClinicalTrials.gov